Skip to main content
ManuSights

Verified provenance

A revision trail you can inspect, not a silent freshness claim.

Every verified dataset release keeps its own evidence date and immutable files. Automated monitoring can flag a page for review, but it cannot rewrite a journal requirement or create a new version by itself.

01Observe

Check the exact official URL with conditional requests and a content fingerprint.

02Review

Treat redirects, blocks, and content movement as signals requiring a second source review.

03Verify

Reconcile the changed claim, sibling sources, owner guide, and downstream decision cells.

04Publish

Issue a new immutable version and keep the superseded release addressable.

Release ledger

Verified dataset versions

Interface improvements are recorded separately from factual dataset revisions, so a UI release cannot masquerade as fresher evidence.

  1. superseded

    Version 1.0

    Initial five-journal source-fragmentation study.

    Evidence reviewed
    2026-08-26
    Study date
    2026-08-18
    Supersedes
    Initial release

    Material contents

    • Mapped 15 official publisher, society, journal, and author-center surfaces.
    • Separated six author decision areas and 16 journal-by-decision evidence cells.
    • Published the typed dataset, CSV, methodology, and canonical guide owners together.
    Open v1.0 JSONDownload v1.0 CSVOpen history JSON
  2. superseded

    Version 1.1

    Cross-disciplinary expansion to ten journals and 30 official source surfaces.

    Evidence reviewed
    2026-08-27
    Study date
    2026-08-27
    Supersedes
    1.0

    Material contents

    • Added Nature Communications, PLOS ONE, Physical Review Letters, ACS Catalysis, and The BMJ.
    • Broadened the purposive sample across multidisciplinary science, physics, chemistry, and medicine.
    • Preserved the initial five-journal release as an immutable, separately addressable baseline.
    Open v1.1 JSONDownload v1.1 CSVOpen history JSON
  3. superseded

    Version 1.2

    Cross-disciplinary expansion to 15 journals and 45 official source surfaces.

    Evidence reviewed
    2026-08-27
    Study date
    2026-08-27
    Supersedes
    1.1

    Material contents

    • Added eLife, the New England Journal of Medicine, The Journal of Finance, Academy of Management Journal, and PNAS.
    • Extended the sample across reviewed preprints, clinical medicine, finance, management, and academy publishing.
    • Preserved both earlier releases as immutable, separately addressable baselines.
    Open v1.2 JSONDownload v1.2 CSVOpen history JSON
  4. superseded

    Version 1.3

    Evidence expansion to 20 journals and 60 official source surfaces.

    Evidence reviewed
    2026-08-27
    Study date
    2026-08-27
    Supersedes
    1.2

    Material contents

    • Added Nature, JAMA, Nucleic Acids Research, American Economic Review, and Management Science.
    • Replaced candidates whose current official source path could not pass the distinct-surface evidence gate.
    • Preserved all three earlier releases as immutable, separately addressable baselines.
    Open v1.3 JSONDownload v1.3 CSVOpen history JSON
  5. superseded

    Version 1.4

    Canonical-owner correction preserving the 20-journal, 60-surface evidence release.

    Evidence reviewed
    2026-08-27
    Study date
    2026-08-27
    Supersedes
    1.3

    Material contents

    • Replaced two redirected guide aliases with their live canonical owner paths.
    • Made no change to the official-source evidence, decision classifications, or study findings.
    • Preserved v1.3 as an immutable, separately addressable evidence release.
    Open v1.4 JSONDownload v1.4 CSVOpen history JSON
  6. superseded

    Version 1.5

    Cross-disciplinary expansion to 25 journals and 75 official source surfaces.

    Evidence reviewed
    2026-08-28
    Study date
    2026-08-28
    Supersedes
    1.4

    Material contents

    • Added Frontiers in Microbiology, JAMA Network Open, Nature Biotechnology, IEEE TPAMI, and PLOS Biology.
    • Extended the maintained evidence layer across microbiology, open-access medicine, biotechnology, computer vision, and biology.
    • Preserved v1.4 and every earlier release as immutable, separately addressable evidence baselines.
    Open v1.5 JSONDownload v1.5 CSVOpen history JSON
  7. superseded

    Version 1.6

    Publisher-diverse expansion to 30 journals and 90 official source surfaces.

    Evidence reviewed
    2026-08-28
    Study date
    2026-08-28
    Supersedes
    1.5

    Material contents

    • Added Science Advances, Chemical Science, Journal of Clinical Oncology, Antioxidants, and The Quarterly Journal of Economics.
    • Added four publisher ecosystems not represented in v1.5: AAAS, the Royal Society of Chemistry, the American Society of Clinical Oncology, and MDPI.
    • Normalized the PLOS ONE publisher entity and removed an unsupported Frontiers disclosure/data mapping while preserving the immutable v1.5 record and every earlier evidence release.
    Open v1.6 JSONDownload v1.6 CSVOpen history JSON
  8. superseded

    Version 1.7

    Reuse and institutional-adoption release preserving the verified 30-journal evidence corpus.

    Evidence reviewed
    2026-08-28
    Study date
    2026-08-28
    Supersedes
    1.6

    Material contents

    • Added explicit CC BY 4.0 terms for Manusights original classifications, arrangement, and teaching materials.
    • Added a structured path for institutions to report a public syllabus, LibGuide, workshop, or repository placement for independent verification.
    • Made no change to the 30 journal records, 90 official source surfaces, or the underlying evidence review.
    Open v1.7 JSONDownload v1.7 CSVOpen history JSON
  9. current

    Version 1.8

    Reproducibility and external-reuse release preserving the verified 30-journal evidence corpus.

    Evidence reviewed
    2026-08-28
    Study date
    2026-08-28
    Supersedes
    1.7

    Material contents

    • Added a machine-readable codebook, reproducibility manifest, file checksums, and deterministic release-bundle builder.
    • Published versioned chart assets and copyable attribution snippets for lawful external reuse without weakening site security headers.
    • Added a deeper cross-journal findings report and DOI, repository-release, source-change, and adoption readiness controls without changing the underlying evidence records.
    Open v1.8 JSONDownload v1.8 CSVOpen history JSON

The evidence boundary

A detected difference is not yet a changed rule.

Publisher pages can redirect, block automation, rearrange markup, or inject dynamic content without changing an author requirement. The daily monitor therefore opens a review task; it never updates the public dataset.

  • Signal: a conditional request, final URL, or normalized content fingerprint differs.
  • Verification: a human reopens the official source and identifies the exact decision affected.
  • Revision: the new claim, prior observation, reason, date, and immutable files publish together.
Read the complete review policy

Follow and archive

Reuse the release trail without scraping the interface.

The Atom feed contains verified releases only. This version is archived on Zenodo with the version-specific DOI 10.5281/zenodo.22215938. Preserve that DOI with the version and evidence date when you cite or reuse the data.

  • Release feed: subscribe to immutable version summaries.
  • Archive metadata: inspect files, license, citation formats, and the deposit boundary.
  • Deposit manifest: inspect the exact repository package and its file-integrity chain.
  • CITATION.cff: import version-specific citation metadata, including the registered DOI.
Open release feedOpen archive metadataOpen deposit manifestOpen repository metadataOpen CITATION.cff